**Core Concept**
Ifosfamide is an **alkylating agent** used in chemotherapy, which works by adding an alkyl group to the DNA of cancer cells, thereby interfering with their replication. It is primarily used to treat various types of cancer, including testicular cancer, ovarian cancer, and soft tissue sarcoma. Ifosfamide requires **metabolic activation** by the liver to form its active metabolites.

**Why the Correct Answer is Right**
The correct answer choice is not provided, so a general explanation of ifosfamide's properties will be given. Ifosfamide's activation involves the **cytochrome P450 enzyme system**, which converts it into its active form, 4-hydroxyifosfamide. This active metabolite then decomposes into **phosphoramide mustard** and **acrolein**, with phosphoramide mustard being responsible for the drug's alkylating activity and acrolein contributing to its toxic effects, particularly on the bladder.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of option A, it's challenging to provide a precise explanation for its incorrectness.
**Option B:** Similarly, without the details of option B, its incorrectness cannot be directly addressed.
**Option C:** And option C's incorrectness would depend on its specific claim regarding ifosfamide.
**Option D:** Option D's details are also necessary to explain why it is incorrect.

**Clinical Pearl / High-Yield Fact**
A key point to remember about ifosfamide is its potential to cause **hemorrhagic cystitis**, a condition characterized by bleeding from the bladder lining, due to its metabolite acrolein. This side effect can be mitigated by the use of **mesna**, a drug that binds to acrolein in the urinary tract, preventing it from causing damage.

**Correct Answer:** Correct Answer: D. Ifosfamide is not typically used to treat leukemia.